Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis
View through CrossRef
Abstract
Background:
Endometriosis (EMS) is one of the common diseases in women, which seriously affects the quality of life of women. Leuprorelin acetate can control the development of EMS, but long-term use can cause perimenopausal symptoms in women. Clinical studies have shown that Kuntai capsule combined with leuprorelin acetate is effective in the treatment of EMS, which can relieve perimenopausal symptoms, but it lacks of evidence-based medical evidence. Therefore, this study aims to systematically evaluate the efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS.
Methods:
CNKI, VIP, Wanfang, Chinese Biomedical Literature Database, PubMed, The Cochrance Library, Embase, Web of Science, and other databases were searched by computer to collect randomized controlled trials of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS. The retrieval time was from the establishment of the database to February 2021. Two researchers screened the literatures and extracted the data and meta-analysis was performed using RevMan 5.3 software.
Results:
This study evaluated the efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS by clinical effective rate, serum sex hormone levels estradiol, follicle-stimulating hormone, luteinizing hormone, visual analogue scale, Kupperman score and incidence of adverse reactions.
Conclusion:
This study will provide reliable evidence-based evidence for the clinical application of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS.
Ethics and dissemination:
Private information from individuals will not be published. This systematic review also does not involve endangering participant rights. Ethical approval will not be required. The results may be published in a peer-reviewed journal or disseminated at relevant conferences.
OSF Registration number:
DOI 10.17605/OSF.IO/AZU47
Ovid Technologies (Wolters Kluwer Health)
Title: The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis
Description:
Abstract
Background:
Endometriosis (EMS) is one of the common diseases in women, which seriously affects the quality of life of women.
Leuprorelin acetate can control the development of EMS, but long-term use can cause perimenopausal symptoms in women.
Clinical studies have shown that Kuntai capsule combined with leuprorelin acetate is effective in the treatment of EMS, which can relieve perimenopausal symptoms, but it lacks of evidence-based medical evidence.
Therefore, this study aims to systematically evaluate the efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS.
Methods:
CNKI, VIP, Wanfang, Chinese Biomedical Literature Database, PubMed, The Cochrance Library, Embase, Web of Science, and other databases were searched by computer to collect randomized controlled trials of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS.
The retrieval time was from the establishment of the database to February 2021.
Two researchers screened the literatures and extracted the data and meta-analysis was performed using RevMan 5.
3 software.
Results:
This study evaluated the efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS by clinical effective rate, serum sex hormone levels estradiol, follicle-stimulating hormone, luteinizing hormone, visual analogue scale, Kupperman score and incidence of adverse reactions.
Conclusion:
This study will provide reliable evidence-based evidence for the clinical application of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS.
Ethics and dissemination:
Private information from individuals will not be published.
This systematic review also does not involve endangering participant rights.
Ethical approval will not be required.
The results may be published in a peer-reviewed journal or disseminated at relevant conferences.
OSF Registration number:
DOI 10.
17605/OSF.
IO/AZU47.
Related Results
IVF/ICSI treatment for patients with diminished ovarian reserve with or without Kuntai capsule pretreatment: a retrospective cohort study stratified by a controlled ovarian stimulation regimen
IVF/ICSI treatment for patients with diminished ovarian reserve with or without Kuntai capsule pretreatment: a retrospective cohort study stratified by a controlled ovarian stimulation regimen
BackgroundKuntai capsules, a traditional Chinese medicine, are speculated to improve the treatment outcomes of patients with ovarian reserve dysfunction (DOR), but existing evidenc...
The effect of Kuntai capsule on ovarian function in cisplatin-induced premature ovarian insufficiency rats
The effect of Kuntai capsule on ovarian function in cisplatin-induced premature ovarian insufficiency rats
ObjectiveThis study aims to evaluate the effect of Kuntai capsule on ovarian function in cisplatin-induced premature ovarian insufficiency rats and to explore the mechanism of Kunt...
O-056 Can we tailor ART to endometriosis patients?
O-056 Can we tailor ART to endometriosis patients?
Abstract
ART remains an effective treatment for endometriosis-associated infertility, although there is evidence that pregnancy rates are diminished in women with en...
Evaluation of PTEN and Ki67 Expression in Typical and Atypical Endometriosis and Endometriosis Associated Ovarian Cancer
Evaluation of PTEN and Ki67 Expression in Typical and Atypical Endometriosis and Endometriosis Associated Ovarian Cancer
Background: Several studies reported that endometriosis is associated with an increased risk of ovarian cancer. Atypical endometriosis is common in patients with endometriosis-asso...
Impact of Kuntai Capsules on LIF, IGF-1 and EGF Expression in the Implantation Window of Endometrium in Mice
Impact of Kuntai Capsules on LIF, IGF-1 and EGF Expression in the Implantation Window of Endometrium in Mice
Objective: This study aims to investigate the influence of Kuntai capsules on the expression level of leukemia inhibitory factor (LIF), insulin-like growth factor-I (IGF-1) and epi...
Kurkumin Menurunkan Ekspresi Tumor Necrosis Factor (TNF)-α Kompleks Oosit-Kumulus Sapi pada Kultur dengan Zalir Peritoneum Penderita Infertil Terkait Endometriosis
Kurkumin Menurunkan Ekspresi Tumor Necrosis Factor (TNF)-α Kompleks Oosit-Kumulus Sapi pada Kultur dengan Zalir Peritoneum Penderita Infertil Terkait Endometriosis
Tujuan: Mempelajari pengaruh pemberian kurkumin terhadap ekspresi tumor necrosis factor (TNF)-α kompleks oosit-kumulus (KOK) sapi pada kultur zalir peritoneum penderita infertil de...
Endometrioma patients are under-treated with endocrine endometriosis therapy
Endometrioma patients are under-treated with endocrine endometriosis therapy
Abstract
STUDY QUESTION
Is there a difference in the use of endocrine endometriosis therapy in endometriosis patients with and w...
O-168 Chronic pelvic pain is the most troublesome endometriosis pain symptom for women’s quality of life
O-168 Chronic pelvic pain is the most troublesome endometriosis pain symptom for women’s quality of life
Abstract
Study question
Which pre-operative endometriosis pain symptom is most troublesome for the quality-of-life of women asse...